BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8995909)

  • 1. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.
    Yustin D; Kryshtalskyj B; Galea A
    J Orofac Pain; 1995; 9(4):375-9. PubMed ID: 8995909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viscosupplementation for osteoarthritis.
    Wright KE; Maurer SG; Di Cesare PE
    Am J Orthop (Belle Mead NJ); 2000 Feb; 29(2):80-8; discussion 88-9. PubMed ID: 10695858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current thinking on viscosupplementation in osteoarthritis.
    Jay GD
    Med Health R I; 2004 Jul; 87(7):213-5. PubMed ID: 15354797
    [No Abstract]   [Full Text] [Related]  

  • 4. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
    Pelletier JP; Martel-Pelletier J
    J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intra-articular administration of sodium hyaluronate on plasminogen activator system in temporomandibular joints with osteoarthritis.
    Tang YL; Zhu GQ; Hu L; Zheng M; Zhang JY; Shi ZD; Liang XH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):541-7. PubMed ID: 20185343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.
    Wobig M; Dickhut A; Maier R; Vetter G
    Clin Ther; 1998; 20(3):410-23. PubMed ID: 9663358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
    Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
    Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
    Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
    J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high molecular weight hyaluronic acid (Hylan G-F 20) on experimentally induced temporomandibular joint osteoartrosis: part II.
    Duygu G; Güler N; Cam B; Kürkçü M
    Int J Oral Maxillofac Surg; 2011 Dec; 40(12):1406-13. PubMed ID: 21889876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
    Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
    Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
    Parenti D; Murray CW
    Arthritis Rheum; 2001 Jun; 44(6):1470-1; author reply 1473-6. PubMed ID: 11407711
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-articular hyaluronic acid injections for knee osteoarthritis.
    Wen DY
    Am Fam Physician; 2000 Aug; 62(3):565-70, 572. PubMed ID: 10950213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of temporomandibular joint osteoarthritis with viscosupplementation and arthrocentesis on rabbit model.
    Xinmin Y; Jian H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Sep; 100(3):e35-8. PubMed ID: 16122644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.
    Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R
    J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H; Burkhardt D; Sambrook P; March L
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
    Balazs EA
    Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment of temporomandibular joint osteoarthrosis: intra-articular injection of sodium hyaluronate.
    Guarda-Nardini L; Masiero S; Marioni G
    J Oral Rehabil; 2005 Oct; 32(10):729-34. PubMed ID: 16159350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?
    Brandt KD; Smith GN; Simon LS
    Arthritis Rheum; 2000 Jun; 43(6):1192-203. PubMed ID: 10857778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.